Results of endovascular interventions for peripheral arterial diseases on the targeted arterial segments.

A Chinaliyev, S Saparbayev, B Zhakiyev, G Chinaliyeva, D Khassenov, I Abdelazim, A Donayeva, A Amanzholkyzy, L Arias, S Shukulov, Z Azhetova, Z Khamidullina
{"title":"Results of endovascular interventions for peripheral arterial diseases on the targeted arterial segments.","authors":"A Chinaliyev, S Saparbayev, B Zhakiyev, G Chinaliyeva, D Khassenov, I Abdelazim, A Donayeva, A Amanzholkyzy, L Arias, S Shukulov, Z Azhetova, Z Khamidullina","doi":"10.26355/eurrev_202410_36868","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Endovascular interventions (EVIs) are an effective and minimally invasive therapeutic option for peripheral arterial diseases (PADs). This study aimed to evaluate the results of EVIs for PADs on the targeted arterial segments (TASs).</p><p><strong>Patients and methods: </strong>One hundred and sixteen (116) participants with PADs were included in this cohort study. The diagnosis of PAD in this study was based on the ankle-brachial index (ABI) and Rutherford classification, confirmed by Duplex ultrasound and computed tomography angiography (CTA). The targeted arterial segments (TASs) were treated using either balloon angioplasty or endovascular stenting. At the end of each EVI, a post-procedure angiography was performed to evaluate the EVIs' results (i.e., balloon angioplasty and endovascular stenting) for PADs on the TASs. The results of EVIs were classified as either satisfactory or unsatisfactory. Satisfactory if the TASs were recanalized or had <30% stenosis after the EVIs. Unsatisfactory if the TASs were still occluded or had >30% stenosis after the EVIs.</p><p><strong>Results: </strong>The mean participants' age was 54.42±7.74 years; 35.3% of them were diabetic, 36.2% were hypertensive, and 28.5% had multiple medical disorders. Based on Rutherford classification, 44.83% of the participants had grade I, category 2 chronic ischemia, 23.28% had grade I, category 3 chronic ischemia, 12.93% had grade II, category 4 chronic ischemia, and 18.96% had grade III, category 5 chronic ischemia. About 87.1% of the participants' PADs were managed using balloon angioplasty. The affected arteries were the superficial femoral arteries in 47.5%, popliteal arteries in 18.8%, posterior tibial arteries in 18.8%, and anterior tibial arteries in 14.9%. About 12.9% of the participants' PADs were managed using endovascular stenting and the affected arteries were the common iliac arteries in 60%, and external iliac arteries in 40%. The results of EVIs were satisfactory in 98.28% of the participants, while it was unsatisfactory in 1.72% of them.</p><p><strong>Conclusions: </strong>Endovascular interventions in this study were an effective and minimally invasive therapeutic option for PADs, with satisfactory results in 98.28%. Further studies, including the long-term and clinical outcomes after EVIs for PADs, are required.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 20","pages":"4451-4460"},"PeriodicalIF":3.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202410_36868","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Endovascular interventions (EVIs) are an effective and minimally invasive therapeutic option for peripheral arterial diseases (PADs). This study aimed to evaluate the results of EVIs for PADs on the targeted arterial segments (TASs).

Patients and methods: One hundred and sixteen (116) participants with PADs were included in this cohort study. The diagnosis of PAD in this study was based on the ankle-brachial index (ABI) and Rutherford classification, confirmed by Duplex ultrasound and computed tomography angiography (CTA). The targeted arterial segments (TASs) were treated using either balloon angioplasty or endovascular stenting. At the end of each EVI, a post-procedure angiography was performed to evaluate the EVIs' results (i.e., balloon angioplasty and endovascular stenting) for PADs on the TASs. The results of EVIs were classified as either satisfactory or unsatisfactory. Satisfactory if the TASs were recanalized or had <30% stenosis after the EVIs. Unsatisfactory if the TASs were still occluded or had >30% stenosis after the EVIs.

Results: The mean participants' age was 54.42±7.74 years; 35.3% of them were diabetic, 36.2% were hypertensive, and 28.5% had multiple medical disorders. Based on Rutherford classification, 44.83% of the participants had grade I, category 2 chronic ischemia, 23.28% had grade I, category 3 chronic ischemia, 12.93% had grade II, category 4 chronic ischemia, and 18.96% had grade III, category 5 chronic ischemia. About 87.1% of the participants' PADs were managed using balloon angioplasty. The affected arteries were the superficial femoral arteries in 47.5%, popliteal arteries in 18.8%, posterior tibial arteries in 18.8%, and anterior tibial arteries in 14.9%. About 12.9% of the participants' PADs were managed using endovascular stenting and the affected arteries were the common iliac arteries in 60%, and external iliac arteries in 40%. The results of EVIs were satisfactory in 98.28% of the participants, while it was unsatisfactory in 1.72% of them.

Conclusions: Endovascular interventions in this study were an effective and minimally invasive therapeutic option for PADs, with satisfactory results in 98.28%. Further studies, including the long-term and clinical outcomes after EVIs for PADs, are required.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
针对目标动脉段的外周动脉疾病血管内介入治疗结果。
目的:血管内介入治疗(EVI)是治疗外周动脉疾病(PAD)的有效微创疗法。本研究旨在评估血管内介入治疗外周动脉疾病对目标动脉段(TAS)的治疗效果:这项队列研究共纳入了 116 名 PAD 患者。本研究根据踝肱指数(ABI)和卢瑟福分类对 PAD 进行诊断,并通过双工超声波和计算机断层扫描血管造影术(CTA)进行确认。目标动脉段(TAS)采用球囊血管成形术或血管内支架术进行治疗。每次 EVI 结束时,都要进行术后血管造影,以评估 EVI(即球囊血管成形术和血管内支架术)对 TAS 上 PAD 的治疗效果。EVI 的结果分为满意和不满意。如果 EVI 后 TAS 再通畅或有 30% 的狭窄,则为满意:参与者的平均年龄为(54.42±7.74)岁,其中 35.3% 患有糖尿病,36.2% 患有高血压,28.5% 患有多种疾病。根据卢瑟福分级,44.83%的参与者患有Ⅰ级2类慢性缺血,23.28%患有Ⅰ级3类慢性缺血,12.93%患有Ⅱ级4类慢性缺血,18.96%患有Ⅲ级5类慢性缺血。约 87.1%的受试者通过球囊血管成形术治疗了 PAD。47.5%的受影响动脉为股浅动脉,18.8%为腘动脉,18.8%为胫后动脉,14.9%为胫前动脉。约 12.9% 的参试者的 PAD 采用了血管内支架治疗,60% 的受影响动脉为髂总动脉,40% 为髂外动脉。98.28%的参与者对血管内支架置入术效果满意,1.72%的参与者对效果不满意:本研究中的血管内介入治疗是治疗 PAD 的有效微创疗法,98.28% 的患者疗效满意。还需要进一步研究,包括 EVI 治疗 PAD 后的长期和临床疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.30
自引率
6.10%
发文量
906
审稿时长
2-4 weeks
期刊介绍: European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)
期刊最新文献
Comparison of regimens targeting complete remission in the first-line treatment of acute myeloid leukemia patients. Diuretic activity of ethanolic extract and fraction enriched in saponins from Solanum sisymbriifolium Lam. root in rats. Evaluation of adropin level and insulin resistance in non-alcoholic fatty liver patients: a meta-analysis of studies. The possible role of serum NGAL and MMP-9 in the assessment of kidney impairment and cardiovascular risk in children and adolescents with type 1 diabetes mellitus or obesity. Exploring factors influencing COVID-19 severity: a matched case-control study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1